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Abstract.  The hybrid plasmid pK4 containing the 
early genes of the simian virus SV-40,  under the con- 
trol of the adenovirus type 5 Ela promoter,  was intro- 
duced into the multipotent embryonal carcinoma (EC) 
1003.  Expression of the SV-40  oncogenes was ob- 
served at the EC cell stage, and this allowed the deri- 
vation of immortalized cells corresponding to early 
stages of differentiation. 
Among the immortalized mesodermal derivatives ob- 
tained, one clone, C1,  is committed to the osteogenic 
pathway. C1  cells have a  stable phenotype, synthesize 
type I collagen, and express alkaline phosphatase ac- 
tivity. Although immortalized and expressing the SV-40 
T  antigen, the cells continue to be able to differentiate 
in vivo and in vitro. In vivo, after injection into syn- 
geneic mice, they produce osteosarcomas. In vitro, the 
cells form nodules and deposit a  collagenous matrix 
that mineralizes, going to hydroxyapatite crystal forma- 
tion, in the presence of/~-glycerophosphate. This 
clonal cell line, which originates from an embryonal 
carcinoma, therefore differentiates into osteogenic cells 
in vivo and in vitro. 
This immortalized cell line will be useful in iden- 
tifying specific molecular markers of the osteogenic 
pathway, to investigate gene regulation during osteo- 
genesis and to study the ontogeny of osteoblasts. 
N~ current view of the development of bone cells is 
that osteocytes derive  from  primitive  mesoblastic 
cell precursors through a cascade of events. These in- 
volve, in the case of intramembranous ossification, (a) pro- 
liferation of primitive mesoblasts, (b) differentiation of these 
cells into an osteoprogenitor cell, then into osteoblasts, and 
(c) maturation of osteoblasts with synthesis of a collagen ma- 
trix and mineralization (5, 10, 39, 44). Up until now, models 
for following bone differentiation in vitro have been of two 
types: (a) osteoblast-like  clones explanted from normal bone, 
and (b) clones derived from osteogenic osteosarcomas. 
(a) The former are normal explanted cells capable of pro- 
gressively synthesizing a bone-like tissue in the presence of 
organic phosphate and ascorbic acid (1, 3, 8, 9, 28, 35, 46). 
This process and its hormonal regulation can therefore be 
studied in vitro.  Collagen I  maturation, in particular,  has 
been extensively studied (11). However, the potential for divi- 
sion of such cells remains limited, and this precludes molec- 
ular studies. In addition, phenotypic changes with loss of os- 
teoblastic properties often occurs in culture (47). 
(b) Clones derived from rat osteosarcomas have also been 
useful in investigating the effects of hormones (parathyroid 
hormone; prostaglandins) and vitamins (retinoids and vita- 
min D3) on bone development (17, 25, 29, 30, 41). The for- 
mation of a mineralized matrix has, however, been shown to 
require  either  the  implantation  of  the  tumoral  cells  in 
diffusion chambers within the animal (43),  or the growth of 
the ceils in agar (37). 
In both model systems, the major problems encountered 
are the heterogeneity of the cell population within a clone, 
and the lack of specific markers allowing formal identifica- 
tion of the progressive stages of osteoblast maturation. 
In this study,  we introduce mouse teratocarcinoma as a 
new model for studying bone differentiation. This system has 
already proven  useful  in  the  study of determination and 
differentiation mechanisms  in  early  embryogenesis.  Ter- 
atocarcinoma tumors contain a wide variety of differentiated 
tissues derived from a multipotent stem cell, the embryonal 
carcinoma (EC) ~ (19).  The differentiated derivatives, how- 
ever, have a limited potential for division, preventing the iso- 
lation of pluripotent progenitors committed to the various re- 
stricted cell lineages. We have recently developed a strategy 
for immortalizing such stem cells from teratocarcinomas. A 
recombinant plasmid, pK4, was constructed, in which the 
SV-40 oncogenes were linked to the adenovirus 5 Ela pro- 
moter. This promoter is active in early embryonic cells (6). 
In a first series of experiments, the plasmid was introduced 
into the EC F9 (20, 22).  Immortalized cells were obtained 
after retinoic acid induction. From these cells, precursors of 
different lineages could be selected and cloned (21). Osteo- 
genic cells were not found among the mesodermal deriva- 
tives. 
In a  series of parallel experiments, pK4 was  introduced 
into 1003 (31), a multipotent EC cell line known to undergo 
1.  Abbreviation used in this paper:  EC,  embryonal carcinoma. 
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in this paper that expression of the SV-40 oncogenes was ob- 
served in 1003-pK4 cells as early as the EC cell stage.  Ex- 
pression did not prevent further differentiation because the 
tumors obtained after injection to syngeneic animals con- 
tained differentiated cells  representative of the  three em- 
bryonic germ layers: neuroectoderm, endoderm, and meso- 
derm. Among the immortalized mesodermal derivatives, we 
were able to select, on the basis of its high expression of the 
bone-specific alkaline phosphatase, a clone, C1, committed 
to the osteogenic pathway. C1 maintains a stable phenotype 
during exponential growth. Upon differentiation in vivo,  it 
gives rise to typical osteosarcomas. In the presence of appro- 
priate  inducers,  it  mineralizes  in  vitro,  forming  dense 
calcified nodules. 
Material and Methods 
Cell Culture and Differentiation Conditions 
1003 cells (7) and their derivatives were routinely grown in DME (Gibco 
Laboratories,  Grand  Island,  NY)  supplemented with  10%  FBS  (Gibco 
Laboratories). 
Cloning by limiting dilution (0.3 cells per 6-mm microtiter wells) was 
performed in multidishes (Costar Corp., Cambridge, MA). Clones 1003 
transformed by pK4 were obtained after cotransfection  of  the embryonal car- 
cinoma 1003 with plasmids pK4 and PSVtkneo/~ using the calcium phos- 
phate precipitation technique as described (21). An intense staining of >10 % 
of the cells with anti-SV-40 T antibodies was detected 48 h after the trans- 
fection. Colonies resistant to Geneticin (Sigma Chemical Co., St.  Louis, 
MO, 400 #g/ml) were isolated and subcloned. 
Ci  cells were routinely grown on tissue-culture dishes in DME sup- 
plemented with 10%  FBS. 
To induce in vitro mineralization, C1 ceils were first seeded on untreated 
plastic dishes (Sterilin, Ltd., Hounslow, UK). After 8 or 15 d, the three 
dimensional clusters formed were either plated onto tissue-culture dishes on 
which they reattached, or maintained as aggregates. After 2 d, the medium 
was shifted to DME supplemented with .1% FBS, and some dishes were 
treated with ascorbic acid (50/zg/ml. Sigma Chemical Co., St. Louis, MO) 
and ~-glycerophosphate  (7 raM, Sigma Chemical Co.). The nodules, which 
developed rapidly,  were fixed for light or electron microscopy. 
Tumor Formation 
2-4  ×  106 cells in 1 ml DME were injected subcutaneously to irradiated 
(600 rad) C3H syngeneic mice. One part of the 1003-pK4-derived tumors 
was fixed in Bouin's fluid and processed for routine histological analysis. 
Another part of the tumor was minced and allowed to grow and differentiate 
in vitro. 
Cl-derived tumors were fixed in 2% glutaraldehyde, dehydrated in alco- 
hol and embedded undecalcified in methacrylate (2,  16). Thick sections (5 
~m) were cut according to conventional methods (2). 
Southern Blot Hybridization of  Genomic DNA 
Aliquots (10 ttg) of genomic and pK4 DNAs were digested by restriction 
endonucleases, electrophoresed on a 0.8 % agarose gel and blot-transferred 
using zetahind membranes (Cuno, Inc., Meriden, CT). Hybridization was 
carried  out  using a  pK4 probe  nick-translated using an  Amersham kit 
(Amersham International, Amersham, UK) (3  x  l0  s cpm]pg). 
Immunocytochemistry 
Indirect immunofluorescence studies on cells were carried out using several 
antisera: (a) mouse mAb Pab 419 (32) detecting viral T antigens and mouse 
mAb ECMA 7 directed against specific EC cell-surface antigens (23); (b) 
affinity-purified rabbit antibodies raised against basal membrane compo- 
nents: collagen I and III (14).  (c) species-specific secondary antisera cou- 
pled to fluorophores (Cappel  Laboratories,  Malvern,  PA)  were used to 
visualize sites of primary antibody binding. 
Fixation and permeabilization of the cells are described in the figure 
legends. 
Controls consisted of cells incubated without primary antibody or with 
nonimmune serum. 
Biochemical Measurements of  cAMP 
The response of Cl cells to 1-34 human parathyroid hormone (PTH; Sigma 
Chemical Co.), prostaglandin E2 (PGE2; Sigma Chemical Co.) and salmon 
calcitonin (CT; kindly provided by Rarer Laboratories, Gennevilliers,  France) 
was evaluated  by determination of the intracellular production of cAMP. 
Confluent cells were treated for 10 min with PTH or the solvent (PBS), 
PGE2 or the solvent (0.1% ethanol) or CT, or the solvent (PBS). Intracellu- 
lar cAMP concentrations were determined in cell lysates using a specific 
RIA (lmmunotech, Luminy,  France). 
Biochemical Measurements of  Alkaline 
Phosphatase Activity 
This was carried out according to previously reported methods (28).  The 
thermosensitivity of the enzyme was checked according to Goldstein et 
al.  (12). 
Histochemical Identification of  Alkaline and Acid 
Phosphatase Activities 
Confluent cells and nodules were fixed at 40C in 95% ethanol. Cells and 
nodule sections were exposed to naphthol ASBI phosphate (30 min, 370C, 
pH 8.6) and naphthol ASTR (Sigma Chemical Co.) (1 h, 37°C, pH 6), used 
as substrates for alkaline and acid phosphatase activities, respectively (28). 
The cells were observed with or without counterstaining with hematoxylin. 
Collagen Analysis 
Confluent cells were labeled for 24 h with 50 #Ci/ml of 4.5  [3H]proline 
(32 Ci/mmol; Commissariat h rEnergie Atomique, Saclay, France) in DME 
supplemented with 1% FBS, 100 #.g/ml ascorbic acid, and 50/zg/ml b-amino- 
propionitrile fumarate (Sigma Chemical Co.). The cells were collected in 
50 mM Tris-HCl (pH 7.4) containing 150 mM NaCI, 25 mM EDTA,  10 
mM N-ethylmaleimide, and 2  mM PMSF,  and pooled with the culture 
medium. After sonication and addition of TCA (10%), the insoluble residue 
was collected by centrifugation. 
The amount of [3H]proline  incorporated into collagenase-digestible pro- 
tein and noncollageneous protein was determined as described (40). 
Collagen types were determined by PAGE: pellets resuspended in 0.5 M 
acetic acid were digested with 100/~g/ml pepsin (Sigma Chemical Co.), pH 
2.0,  for 4 h at 4°C. The pepsin digest brought to pH 8.0 was dialyzed and 
lyophylized. Samples were then analyzed by SDS-PAGE. Delayed reduction 
with 2-mercaptoethanol was used in some samples. Labeled proteins were 
visualized by fluorography. 
Histological Detection of  Collagen and Minerals 
After 15 d of culture in the presence or absence of ascorbic acid and ~-glyc- 
erophosphate, the nodules formed were collected, fixed in 95 % ethanol, and 
embedded in glycolmethacrylate. 5-p,m-thick sections were stained with to- 
luidine blue, Von Kossa, or Goldner Trichrome for the detection of collagen 
and minerals (2, 28). 
Electron Microscopy, X-Ray Microanalysis, 
and X-Ray Diffraction 
The calcified nodules formed in differentiated C1 cultures were fixed in situ 
with 2% glutaraldehyde in 0.1 M sodium cacodylate (pH 7.2, 20 rain). The 
nodules were post-fixed in  1%  osmium tetroxide (15  min),  rinsed, de- 
hydrated in acetone, and embedded in Epon. Ultra-thin sections stained with 
2.5%  uranyl-acetate and lead citrate were examined using a Siemens EI- 
miskop 101  electron microscope (Siemens-Allis, Inc., Cherry Hill,  N  J). 
Mineralized spots were analyzed on carbon-coated sections using energy 
dispersive x-ray  microanalysis (Tracor Northern, Middleton, WI).  X-ray 
diffraction analysis of the calcifying structure was performed and calibrated 
using an aluminum standard. 
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Selection and Cloning of  an Immortalized Osteogenic 
Clone  from pK4-transformed Teratocarcinoma 
Expression  of the pk4 Genome  at the EC Cell Stage in 
Transformed 1003-pK4 Clones.  1003 EC cells were cotrans- 
fected with plasmids pK4 and PSVtk-neo/~.  Geneticin resis- 
tant clones were then selected. Out of 15 clones analyzed, 
3 (clones 8120, 8212, and 8129) had integrated the pK4 plas- 
mid, as shown by analysis of the cellular DNA by Southern 
blot hybridization. As indicated by the restriction fragment 
pattern, the integrated plasmid DNA was grossly intact.  1-3 
integrated copies were detected depending on the analyzed 
clone (Fig.  1, top). All three clones expressed the SV-40 T 
antigen in  100% of cell nuclei (Fig.  1,  C and D). 
Further analysis of the transformed clones (1003-pK4) re- 
vealed that the cells had remained undifferentiated, as judged 
by their morphology, the persistence of the expression of 
specific markers of EC cells (4, 23) (Fig.  1, A and B), and 
their potential to differentiate, when submitted to a suitable 
environment, into derivatives of the three embryonic germ 
layers. Except for the integration of the plasmid and the ex- 
pression of the SV-40 oncogenes, the 1003-pK4 cells could 
not be distinguished from the parental EC  1003.  We con- 
clude that the SV-40 T antigen can be expressed in 1003-pK4 
cells as early as the EC stage, and that the presence of the 
T antigen neither causes recognizable phenotypic change nor 
prevents differentiation in vivo or upon in vitro induction. 
Selection  of an Osteogenic Clone among Immortalized 
Mesodermal  Derivatives.  Each  of  the  three  1003-pK4 
clones  was  injected  into  irradiated  syngeneic  mice.  Ter- 
atocarcinomas were produced within  1-3 mo in all inocu- 
lated animals. They were composed of EC cells, and of vari- 
ous  differentiated derivatives of the three germ layers.  In 
cultures derived from the tumor, most cells expressed the 
SV-40 T  antigen. 
One tumor arising from 1003-pK4 clone 8129 was allowed 
to grow in vitro. Areas containing mature mesodermal deriv- 
atives closely associated with immature cells were selected 
with the idea that the immature cells might correspond to 
mesodermal progenitors. Clones harboring various pheno- 
types were isolated from this mesodermal population by lim- 
iting dilution in Costar multidishes (0.3 cell per well).  All 
clones expressed the SV-40  T  antigen (Fig.  2,  A and B). 
Among them, myoblast-like clones giving rise at confluence 
to multinucleated myotubes (Fig. 2, C and D). Some clones 
were enriched in adipoblasts and adipocyte-like cells con- 
taining lipid droplets (Fig. 2 E). Others were fibroblast-like 
(Fig. 2 F) or exhibited a mixed phenotype (Fig. 2 H). Fi- 
nally,  some  clones  were  composed of polygonal cells of 
unidentified phenotype (Fig. 2  G). To screen for the pres- 
ence of an osteogenic precursor among the immature cells, 
the  various  subpopulations  were  injected  into  syngeneic 
mice. The tumors formed contained only mesodermal deriv- 
atives. The polygonal cells gave rise in all cases to tumors 
containing mesoblastic cells,  osteoblast-like cells oriented 
around host capillaries,  and developing bone.  Transitional 
stages  between the  immature cells  and  mineralized bone 
were present in all the tumors (not shown). The cell popula- 
tion arising from one tumor (87102) was further cloned by 
limiting dilution. Clones were selected on the basis of their 
Figure 1. (Top) Southern hybridization analysis of genomic DNA 
from 1003-pK4 transfected clones. Digestion by Eco RI and Pvu 
II (size of the fragments: 3.6 and 1.8 kb). Lanes a, c, and e: trans- 
formed clones 8120, 8212 and 8129, respectively. Lanes b and d: 
untransformed clones 8230 and 8209.  1,  3,  10, or 30 copies of 
digested pK4 were used for calibration. (Bottom) lmmunofluores- 
cence staining of the  1003-pK4 transformed clone 8129 with A. 
ECMA seven antibodies recognizing EC cell-surface antigens. Fix- 
ation  with  3%  paraformaldehyde. (C)  mAb against T  antigen. 
Methanol fixation at -20°C. (B and D) Phase-contrast micrographs 
of the same fields. Bar, 10 ttm.  x400. 
polygonal morphology and of their high level of bone spe- 
cific heat-labile alkaline phosphatase activity (Table I). One 
clone, C1, was  selected for further analysis. 
Properties of the Osteogenic Clone C1 
Characteristics of  the Precursor Cell. C1 cells exhibit a po- 
lygonal morphology (Fig. 3 A). All the cells of the clone, ex- 
Kellermann ¢t al. Immortalized  Osteogenic Cell Line  125 Figure 2. Phenotypes of the mesodermal clones derived from a 1003-pK4 teratocarcinoma. (A) Phase-contrast and (B) immunofluorescence 
labeling with mAb against T antigen of an immature, mesoblastic like clone. Bar,  10 #m  ×800.  (C and D) Myoblast-like cells and the 
same clone showing multinucleated myotubes at confluence. (E) Adipocytes. (F) Fibroblasts. (G) Polygonal cells of unidentified phenotype. 
(H) mixed phenotype. Bar, 50 ttm.  x200. 
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Total activity  Heat-labile activity 
~umol PNP/mg protein per min 
Embryonal carcinoma  1003  0.01  ±  0.001  0.01  +  0.002 
Embryonal carcinoma  1003-pK4  0.01  ±  0.002  0.01  ±  0.001 
Tumor 87102  0.21  ±  0.02  0.20  ±  0.02 
Clone F1  0.02  ±  0.003  0.02  ±  0.003 
Clone C1  0.23  +  0.05  0.27  ±  0.03 
Cells were plated in DME containing  10%  FBS at 4  ×  10  ~ cells/cm 2. When 
the cells were confluent, they were first washed with DME and then cultured 
for a further 24 h in serum-free DME. The cells were scraped, cell lysates were 
collected and sonicated,  and alkaline phosphatase activity was determined  in 
cell lysates. Values are the mean ±  SEM of four independent confluent cultures. 
press the SV-40 T antigen in their nucleus (Fig. 3 B). When 
growing exponentially, the clonal cell population has a dou- 
bling  time of 30 h  and  maintains  a  stable,  homogeneous 
phenotype for over 100 generations. 
C1 cells synthesize type I collagen, a characteristic feature 
of osteoblastic cells (1). At confluence, collagen represents 
8.2 +  1.4% (n =  4) of total protein, as assessed by collagen- 
ase  digestion  of [3H]proline-labeled Cj  cells.  SDS-PAGE 
analysis of  the proteins digested with pepsin shows two major 
bands  comigrating with standard cd(1) and a2(1) collagen 
chains.  Collagen type III chains are not detectable (Figs. 4 
and 5A). 
Figure 3. CI clone. (A) Phase-contrast micrograph. (B) Immunotlu- 
orescence staining with a mAb against T antigen. (C) control with- 
out primary antibody. Methanol fixation at  -20°C. Bar, 20/zm. 
x300. (D) Staining with anti-T antibody of a cell culture derived 
from C1 osteosarcoma. Bar, 50 #m.  x120. 
Table II. lntracellular cAMP Production by C1 Cells 
cAMP 
M  pmol/mg protein 
11.8  ±  0.2* 
10  -j°  20.6  +  0.8* 
10  -9  49.7  ±  9.3* 
10  -8  89.1  ±  9.6* 
10  -7  102.7  5:  6.2* 
7.0  ±  1.5 
10  -8  7.1  ±  0.8 
10 -6  4.4  ±  0.8 
2.7  -t- 0.2 
10  -8  3.6  ± 0.4 
10  -7  4.3  ± 0.25* 
10  -6  7.2 ± 0.6* 
Controls (PBS) 
(I-34)hPTH 
Controls (PBS) 
CT 
Controls (ethanol) 
PGE2 
CI  cells  were  cultured  in  DME  with  10%  FBS.  At  confluence cells  were 
washed, cultured in DME and 0.1 mM isobutylmethylxantine (IBMX) for 1 h. 
The cells were then washed and treated in DME with 0.1  mM IBMX for 10 
min in presence of the compounds or their vehicle. The cells were scraped and 
cAMP concentrations were determined in cell lysates. Values are the mean + 
SEM of three to four independent confluent cultures. 
* Significant difference with the appropriate control (P < 0.05 or better level 
of significance by t test). 
Alkaline phosphatase activity is revealed in most of the C1 
cells. The parental clones 1003 and 1003-pK4 also express 
alkaline  phosphatase,  a  marker of embryonal carcinomas 
and of germinal cells (4). However, as illustrated in Table I, 
alkaline phosphatase activity levels present in extracts of C1 
cells are much higher than those in 1003 and 1003-pK4, or 
in the fibroblastic-like clone F1.  The osteosarcoma 87102 
from which C1 and F1 were cloned, also shows a high level 
of alkaline phosphatase activity. 
Moreover, most of the C1 enzymatic activity (95 %) is lost 
upon heating to 56°C for 30 min (Table I), a characteristic 
of  bone-specific  alkaline  phosphatase  (12).  In  addition, 
59.6% of the alkaline phosphatase activity (p <  1,000) are in- 
hibited by physiological doses of 1,25 dihydroxyvitamin D3 
[1,25(OH)2D]  (10  -8 M).  Furthermore, C1  cells are respon- 
sive to PTH and PGE2 but not to CT in terms of stimulation 
of cAMP production, another characteristic feature of os- 
teoblastic cells (Table II) (29, 30). 
A significant amount of acid phosphatase activity is found 
in the cytoplasm of the cells (not shown).  Such an activity 
was recently demonstrated in vivo in rat osteoblasts and os- 
teocytes (5). 
Differentiation  In  Vivo. When  injected subcutaneously 
into irradiated syngeneic mice,  the SV-40-transformed C1 
cells develop tumors, found to be typical osteosarcomas. The 
tumors maintain their histological features after serial pas- 
sages in vitro and in vivo. They form a dense trabecular bone 
network with extensive vascularization.  Several trabeculae 
of calcified bone matrix are regularly arranged within the os- 
teosarcoma.  Numerous  bone  forming cells  are  dispersed 
along the bone matrix, some of which are embedded like os- 
teocytes (Fig. 6). Bone resorption by osteoclast-like cells ap- 
pears in some areas, but host marrow cells are not apparent. 
C1 cells are therefore able to form and mineralize in vivo 
a  calcified matrix similar to immature spongiosa.  The os- 
teosarcoma cells must moreover originate from the in vivo 
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tures were labeled with [3H]proline for 24 h.  Cell extracts and 
medium were digested with pepsin, dialyzed and subjected to SDS- 
PAGE, with (left) or without (right) delayed reduction by/3-mercap- 
toethanol. The mobility of the references, type I collagen c~, (I) and 
a2(I) and of type III collagen a~(III) are indicated. 
differentiation of C1 since they express the SV-40 T antigen 
in the tumor. 
Differentiation and Maturation In Vitro. In vitro differ- 
entiation of cells of the immature clone C1 into cells able to 
mineralize was found to require several conditions: (a) the 
addition of ascorbic acid, which enabled C1 cells to produce 
an abundant extracellular matrix. Immunocytochemical (Fig. 
5 A) and biochemical analysis (Fig. 4) revealed that the ma- 
trix contained type I  collagen,  whereas  type III collagen 
could not be detected. (b) a clustering of the cells (see Mate- 
rial and Methods), which was a prerequisite for mineraliza- 
tion (1, 3, 8, 35), and led by day 10 to the formation of numer- 
ous large nodules composed of cells staining intensively for 
alkaline phosphatase activity (Fig. 5, B and C) and surround- 
ed by a dense fibrous material. (c) In the absence of B-glycer- 
ophosphate, no calcification of the nodular structures was 
seen (Fig. 5 E). When/3-glycerophosphate was added, the 
matrix reached complete mineralization as revealed by posi- 
tive  Von  Kossa  staining.  The  nodules  were composed of 
mineralized bone-like matrix deposited by the C1 cells, some 
of which being embedded within the matrix as osteocyte-like 
cells (Fig.  5 F). 
Electron  microscopic examination  showed  that  the  un- 
treated CI cells were surrounded by a dense matrix of stri- 
ated collagen. Upon addition of B-glycerophosphate, miner- 
als were found to be structurally associated with the striated 
collagen fibrils (Fig. 7). 
Prominent peaks of calcium and phosphorus were detected 
in the profiles of the mineralized regions (Fig.  8 A), using 
energy dispersive x-ray analysis. P/Ca ratios were close to 
the 0.6 value of hydroxy apatite (0.56 +  0.01). Furthermore, 
electron diffraction patterns of the same zones demonstrated 
that the minerals had the characteristic crystalline structure 
of hydroxyapatite (Fig.  8 B). 
Discussion 
In a recent report (21), we have introduced a method to derive 
various  immortalized precursors  of the  neuroectodermal, 
mesodermal, and endodermal pathways from the embryonal 
carcinoma F9. This method is based upon the transformation 
of F9 cells by a plasmid, pK4, carrying the SV-40 early genes 
under the under the control of the adenovirus Ela promoter. 
The transformed F9 cells differentiated upon addition of ret- 
inoic acid to the cultures (20, 21). The expression of SV-40 
oncogenes  in  the  transformed  F9  cells  accompanied  the 
differentiation. 
In this work, the plasmid pK4 is introduced into another 
EC cell line, 1003. In contrast with the case of F9 EC cells, 
expression of the SV-40 oncogenes in  1003 cells is realized 
as soon as the EC stage and does not require the induction 
of differentiation. Note that the oncogene expression does 
not induce differentiation (33, 34) and does not alter the mul- 
tipotentiality of the EC cells, as indicated by the presence of 
the  expected  differentiated derivatives  of the  three  germ 
layers within tumors from mice inoculated with the trans- 
formed  1003  clones.  In particular,  among the derivatives, 
committed precursors of the mesodermal lineage were cloned. 
This study both generalizes and extends our earlier obser- 
vations. The recombinant plasmid pK4 is clearly of a poten- 
tial interest for delineating molecular mechanisms leading to 
the expression of the SV-40 T  antigen in embryonal carci- 
noma cells through comparative studies of 1003 and F9 cells 
(24, 26, 42). pK4 also appears to be a valuable tool for estab- 
lishing stable cell lines corresponding to progenitor cells. It 
promotes immortalization at an early stage, while still allow- 
ing the expression of differentiation programs. 
This study is devoted to the characterization of an osteo- 
genic clone, CI. CI isolation required several steps: transfec- 
tion of an embryonal carcinoma cell line known for its high 
efficiency  of  mesodermal differentiation, selection of  a tumor 
giving rise to many mesodermal derivatives, cloning from 
this  tumor in  search of the presence of osteogenic clones 
among mesodermal derivatives, and finally selection of the 
clones for their osteogenic potential in vivo and their high 
activity of bone-specific alkaline phosphatase in vitro (18, 27). 
CI  cells  are  clearly committed towards  the  osteogenic 
pathway.  (a) After injection into syngeneic mice, they pro- 
duce typical osteosarcomas which indeed originate from the 
de novo differentiation of C1, as shown by the expression of 
the SV-40 T antigen in the tumors. (b) In vitro, CI cells ex- 
press osteoblast phenotypic markers, including synthesis of 
type I collagen (1), expression of the bone-specific alkaline- 
phosphatase isoenzyme (12) and osteogenic potential in vivo 
and in vitro. (c) In addition, C1 cells respond to normal bone 
maturation effectors, such as PTH, prostaglandins, and 1,25 
(OH)2 D3 but do not respond to calcitonin. (d) Upon differ- 
entiation in nodular structures induced by ascorbic acid and 
~-glycerophosphate, a collageneous matrix is deposited and 
mineralizes forming bone-like structures, with minerals ma- 
turating into hydroxyapatite crystals. 
Thus, C1 cells appear to be a reliable and convenient sys- 
tem to study osteogenesis in vitro as well as in vivo. Indeed, 
previously described rat osteosarcoma cell lines did not pro- 
duce a mineralized bone matrix unless they were cultured in 
agar (37), or were in close contact with extracellular stimula- 
tory factors diffusing through diffusion chambers (43).  In 
The Journal of Cell Biology, Volume  110,  1990  128 Figure 5. In vitro differentiation of CI cells.  (,4) Immunofluorescence with anticollagen I antibodies showing intracellular staining of ex- 
ponentially growing cells. Fixation with 3% pFA, then with methanol.  Bar, 10 tzm. x800.  (B) Calcified nodule grown in the presence 
of ascorbic  acid and/~-glycerophosphate.  Bar, 50/~m.  xl00.  (C-F) Transverse sections (5/~m thick) of undecalcified nodules. Culture 
in suspension for 21 d in the absence (C and E) or in the presence (D and F) of/~-glycerophosphate and ascorbic acid. (C) Intense membrane- 
bound alkaline phosphatase activity without mineralization.  (D) Toluidine blue-stained  section showing a large mineralized matrix (m) 
surrounded by alkaline-phosphatase-positive cells. (E) Von Kossa staining showing the absence of mineralization. (F) calcified matrix and 
osteocyte-like cells (arrows) embedded within the mineralized matrix.  Bar, 50 ftm.  x200. 
mice, bone formation arising after injection of a teratocar- 
cinoma-derived untransformed cell line has been described 
(36).  However, the  resulting osteochondrosarcoma tumors 
were not formally related to the in vivo differentiation of the 
injected cells and no clonal cell line expressing in vitro an 
osteogenic phenotype could be obtained. It is noteworthy to 
mention also the work of Silbermann et al.  (44) who used 
viruses containing an active v-fos oncogene to transform in 
vitro embryonic murine condyles.  After injection in mice, 
highly abnormal bone-like metastatic tumors were obtained. 
However, these metastatic tumors contrast with our C1 cell 
system, because the bone obtained upon CI differentiation 
has histological features typical of normal immature bone, 
and since the Cl-derived tumors have no metastatic proper- 
ties despite the expression of the early SV-40 oncogenes. Fi- 
nally, a recombinant retrovirus containing the SV-40 T anti- 
gen was recently used to immortalize rat calvaria cells. The 
immortalized cell  lines obtained were shown to  retain os- 
teoblastic properties (15).  As compared with the  Calvaria 
cell lines, C1 cells have two additional features. Firstly, the 
Kellermann et al. Immortalized Osteogenic Cell Line  129 Figure 6. Section of an osteosarcoma derived from C1 cells: dense 
trabecular bone network with extensive vacularization. Osteocytes 
embedded in the bone matrix (arrows).  Bar, 50 #m.  :,<200. 
cells are osteogenic in vitro, allowing the study of gene regu- 
lation during matrix mineralization. Secondly, it should be 
recalled that the C1  clone derives from an island of cells 
resembling the somitic mesoderm of the early embryo. This 
island was composed of mesoblastic cells able to differentiate 
into either myogenic, fibroadipogenic, or osteogenic deriva- 
tives.  The study of various clones representative of those 
mesoblastic cells is now under way. Hopefully, some of these 
clones may correspond to immortalized stages of bone com- 
mitment earlier than the C1 stage.  This idea is supported by 
a recent report (13) showing that progenitor cells in a bone- 
derived clonal cell population from rat can differentiate into 
bone as well as into muscle, fat, or cartilage. Therefore, our 
immortalized teratocarcinoma-derived system appears to be 
of interest to study also the regulation of mesenchymal stem 
cell differentiation. 
In conclusion, the teratocarcinoma-derived clone C1 offers 
the advantages associated with both osteosarcoma-derived 
cell lines having the potential for proliferation, and osteo- 
blastic-like clones derived from normal bone,  having the 
ability  to  differentiate in  vitro into  osteogenic cells.  The 
potential of the C1  cells for proliferation and their stable 
phenotype will give the possibility to obtain large amounts 
of homogeneous material corresponding either to exponen- 
tially growing precursor cells or to cells induced to differen- 
tiate.  Differential screening with other mesoblastic clones 
and  with the initial embryonal carcinoma may permit the 
identification of specific molecular markers for the osteo- 
genic pathway (38), the investigation of gene regulation dur- 
ing osteogenesis, and the study of the ontogenesis of osteo- 
blasts. 
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